These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 35585975)

  • 21. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y; Seto E
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone acetylation and deacetylation - Mechanistic insights from structural biology.
    Patel AB; He Y; Radhakrishnan I
    Gene; 2024 Jan; 890():147798. PubMed ID: 37726026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical and structural biology of protein lysine deacetylases.
    Yoshida M; Kudo N; Kosono S; Ito A
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(5):297-321. PubMed ID: 28496053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMR profiling of histone deacetylase and acetyl-transferase activities in real time.
    Dose A; Liokatis S; Theillet FX; Selenko P; Schwarzer D
    ACS Chem Biol; 2011 May; 6(5):419-24. PubMed ID: 21302972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. K-acetylation and its enzymes: overview and new developments.
    Aka JA; Kim GW; Yang XJ
    Handb Exp Pharmacol; 2011; 206():1-12. PubMed ID: 21879443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.
    Li G; Tian Y; Zhu WG
    Front Cell Dev Biol; 2020; 8():576946. PubMed ID: 33117804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in class IIa histone deacetylases research.
    Asfaha Y; Schrenk C; Alves Avelar LA; Hamacher A; Pflieger M; Kassack MU; Kurz T
    Bioorg Med Chem; 2019 Nov; 27(22):115087. PubMed ID: 31561937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysine acetylation and cancer: A proteomics perspective.
    Gil J; Ramírez-Torres A; Encarnación-Guevara S
    J Proteomics; 2017 Jan; 150():297-309. PubMed ID: 27746255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of transcription factor YY1 by acetylation and deacetylation.
    Yao YL; Yang WM; Seto E
    Mol Cell Biol; 2001 Sep; 21(17):5979-91. PubMed ID: 11486036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein acetylation and deacetylation in plant-pathogen interactions.
    Wang J; Liu C; Chen Y; Zhao Y; Ma Z
    Environ Microbiol; 2021 Sep; 23(9):4841-4855. PubMed ID: 34398483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein Acetylation in Bacteria.
    VanDrisse CM; Escalante-Semerena JC
    Annu Rev Microbiol; 2019 Sep; 73():111-132. PubMed ID: 31091420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Post-Translational Acetylation and Deacetylation of Signaling Proteins and Transcription Factors after Cerebral Ischemia: Facts and Hypotheses.
    Demyanenko S; Sharifulina S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysine Deacetylases and Regulated Glycolysis in Macrophages.
    Shakespear MR; Iyer A; Cheng CY; Das Gupta K; Singhal A; Fairlie DP; Sweet MJ
    Trends Immunol; 2018 Jun; 39(6):473-488. PubMed ID: 29567326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylases: target enzymes for cancer therapy.
    Mottet D; Castronovo V
    Clin Exp Metastasis; 2008; 25(2):183-9. PubMed ID: 18058245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Building a KATalogue of acetyllysine targeting and function.
    Downey M; Baetz K
    Brief Funct Genomics; 2016 Mar; 15(2):109-18. PubMed ID: 26512033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of histone deacetylases inhibitors in glioblastoma.
    Chen R; Zhang M; Zhou Y; Guo W; Yi M; Zhang Z; Ding Y; Wang Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):138. PubMed ID: 32682428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress, thiol redox signaling methods in epigenetics.
    Sundar IK; Caito S; Yao H; Rahman I
    Methods Enzymol; 2010; 474():213-44. PubMed ID: 20609913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
    Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
    Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents.
    Langley B; Gensert JM; Beal MF; Ratan RR
    Curr Drug Targets CNS Neurol Disord; 2005 Feb; 4(1):41-50. PubMed ID: 15723612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.